Related Experiment Video
Updated: Jul 19, 2026

A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
Dietary sodium restriction alters postprandial ghrelin: implications for race differences in obesity
Kimberly A Brownley1, Kathleen C Light, Karen M Grewen
1Department of Psychiatry, University of North Carolina at Chapel Hill 27599-7175, USA. kbrownle@med.unc.edu
Objectives:
To examine the effect of sodium restriction on the appetite-stimulating hormone, ghrelin, as a function of race, salt sensitivity, and obesity.
Design:
PARTICIPANTS completed two 4-day outpatient dietary interventions (moderate vs low sodium), and blood samples were drawn two hours after a controlled test meal under both conditions.
Setting:
A university research laboratory and affiliated General Clinical Research Center.
Participants:
37 women (18 Black, 19 White) and 18 men (9 Black, 9 White), aged 36-63 years.
Measures:
Cardiovascular function (blood pressure, heart rate, impedance-derived indices of cardiac output and peripheral resistance) was measured after a 20-minute rest before each test meal. Blood was drawn by intravenous forearm catheter two hours after each test meal and later assayed for ghrelin, leptin, and norepinephrine.
Results:
After four days of sodium restriction, postprandial ghrelin increased in White men and women and Black men but decreased in Black women. Salt sensitivity, but not obesity, was also related to ghrelin response during sodium restriction; postprandial ghrelin tended to increase among salt-sensitive subjects during salt restriction but decrease among salt-resistant subjects during salt restriction.
Conclusions:
Satiety hormone dysregulation may play a role in: 1) the heightened obesity-related morbidity among Black women, in particular; 2) adherence to sodium-restricted diets; and 3) race differences in behavioral weight-loss interventions that include sodium restriction.
Related Concept Videos
Regulation of Food Intake
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
